AMEX:PTN
Palatin Technologies, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
palatin.comipo date
Oct 15, 1997
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agon...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus